Inventor
OLIVEIRA CARLOS
US12 patents
⚠️ This page may combine multiple inventors who share the name “OLIVEIRA CARLOS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIODESIX INC
11 patentsUS10489550B2Nov 26, 2019
Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample
BIODESIX INC13 citations83
US9779204B2Oct 3, 2017
Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample
BIODESIX INC7 citations83
US10217620B2Feb 26, 2019
Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry
BIODESIX INC6 citations82
US10037874B2Jul 31, 2018
Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry
BIODESIX INC6 citations82
US10007766B2Jun 26, 2018
Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC9 citations81
US10713590B2Jul 14, 2020
Bagged filtering method for selection and deselection of features for classification
BIODESIX INC5 citations71
US10950348B2Mar 16, 2021
Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC2 citations70
US11150238B2Oct 19, 2021
Method for identification of cancer patients with durable benefit from immunotherapy in overall poor prognosis subgroups
BIODESIX INC1 citations62
US11710539B2Jul 25, 2023
Predictive test for melanoma patient benefit from interleukin-2 (IL2) therapy
BIODESIX INC1 citations60
US12230398B2Feb 18, 2025
Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC0 citations56
US12094587B2Sep 17, 2024
Apparatus and method for identification of primary immune resistance in cancer patients
BIODESIX INC1 citations55